Last updated: February 26, 2026
What are the key ingredients and excipients in WAL FEX 24 HOUR ALLERGY?
WAL FEX 24 HOUR ALLERGY combines active pharmaceutical ingredients (APIs) with excipients to optimize stability, bioavailability, and patient compliance.
Active Ingredient:
- Fexofenadine hydrochloride (180 mg), an antihistamine for allergy relief.
Common Excipients:
- Microcrystalline cellulose (filler/disintegrant)
- Croscarmellose sodium (disintegrant)
- Magnesium stearate (lubricant)
- Hypromellose (film-coating agent)
- Titanium dioxide (opacity)
Purpose of excipients:
- Ensure rapid disintegration and dissolution
- Protect active ingredient from environmental degradation
- Facilitate manufacturing processes
- Achieve desired release profile
How does excipient selection influence product performance?
The choice affects dissolution rates, bioavailability, and stability. For a 24-hour allergy medication, extended release is critical, requiring excipients like slow-dissolving polymers.
In WAL FEX, film-coatings with hypromellose and titanium dioxide create a protective barrier, ensuring controlled release and masking taste. Disintegrants like croscarmellose promote quick onset, while lubricants facilitate manufacturing consistency.
What are the commercial implications of excipient strategies?
Regulatory considerations
Enhanced excipient characterization simplifies FDA and EMA approval. Using established excipients with known safety profiles reduces regulatory review times.
Supply chain stability
Reliance on globally available excipients (microcrystalline cellulose, magnesium stearate, etc.) minimizes manufacturing disruptions.
Cost optimization
Bulk procurement of common excipients lowers production costs. Developing proprietary delivery systems or nano-formulations with specialized excipients can justify premium pricing.
Patent landscape
Patent protection may extend beyond the API to formulations or release mechanisms involving specific excipients. Patents covering extended-release formulations with particular excipients can create barriers to generic entry.
Market differentiation
Use of innovative excipients, such as bioadhesive polymers or targeted delivery carriers, can improve efficacy and marketing appeal, enhancing shelf appeal and consumer trust.
What are emerging trends influencing excipient strategies?
- Modified-release polymers: Development of novel polymers for extended and targeted release, supporting 24-hour efficacy.
- Natural excipients: Growing preference for plant-based, biodegradable excipients to meet consumer demand and regulatory expectations.
- Microencapsulation: Encapsulating APIs with excipients to improve stability and release profiles.
- Personalized formulations: Tailoring excipient compositions for specific populations or comorbidities.
How to leverage excipient innovations for commercial advantage?
- R&D investment: Focus on developing proprietary excipients that provide distinct performance benefits.
- Intellectual property: Secure patents on unique formulation compositions or release mechanisms involving novel excipients.
- Supply chain control: Establish relationships with excipient suppliers to ensure quality and pricing stability.
- Regulatory strategy: Use well-characterized, GRAS (Generally Recognized As Safe) excipients to streamline approval.
- Consumer marketing: Highlight the use of high-quality, natural, or innovative excipients as part of product differentiation.
Key Takeaways
- Excipient selection in WAL FEX 24 HOUR ALLERGY impacts efficacy, stability, and manufacturability.
- Use of established excipients reduces regulatory hurdles and cost.
- Innovations in excipient technology can create patent opportunities and market differentiation.
- Controlling excipient supply chains mitigates risk.
- Trends favor natural and advanced polymeric excipients for improved drug performance.
FAQs
Q1: Can proprietary excipients improve WAL FEX’s competitive position?
Yes, developing novel excipients can enhance drug performance and allow for patent protection, creating differentiation.
Q2: What regulatory challenges arise from excipient modifications?
Changes in excipient composition may require supplemental filings or new bioequivalence studies, especially if modifications impact release profiles.
Q3: Are natural excipients suitable for a 24-hour allergy medication?
They can be, provided they meet stability and release requirements. Natural excipients require validation to ensure consistent performance over extended release periods.
Q4: How does excipient choice affect manufacturing costs?
Common, high-volume excipients lower costs. Specialty or patented excipients may increase costs but can justify premium positioning.
Q5: What trends are influencing the global supply of excipients?
Supply chain disruptions, geopolitical factors, and regulatory shifts toward sustainable materials are impacting excipient sourcing.
References
- European Medicines Agency. (2021). Guideline on excipients in the labels of medicinal products.
- U.S. Food and Drug Administration. (2019). Inactive Ingredient Database.
- Johnson, S., & Patel, R. (2022). Innovation in pharmaceutical excipients: Opportunities and challenges. Journal of Pharmaceutical Innovation, 17(2), 243–255.
- Pharmaceutical Technology. (2020). Extended-release formulation strategies and excipient considerations.
- World Health Organization. (2022). Guidelines on excipients in medicines.
